These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9189224)

  • 1. HIV-1 and HIV-2 AIDS in African patients living in Paris.
    Matheron S; Mendoza-Sassi G; Simon F; Olivares R; Coulaud JP; Brun-Vezinet F
    AIDS; 1997 Jun; 11(7):934-6. PubMed ID: 9189224
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen.
    Olsen CH; Gatell J; Ledergerber B; Katlama C; Friis-Møller N; Weber J; Horban A; Staszewski S; Lundgren JD; Phillips AN;
    AIDS; 2005 Feb; 19(3):319-30. PubMed ID: 15718843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda.
    Kaleebu P; French N; Mahe C; Yirrell D; Watera C; Lyagoba F; Nakiyingi J; Rutebemberwa A; Morgan D; Weber J; Gilks C; Whitworth J
    J Infect Dis; 2002 May; 185(9):1244-50. PubMed ID: 12001041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of psychiatric disorders in a cohort of HIV/AIDS patients in South Africa: a 6-month follow-up study.
    Olley BO; Seedat S; Stein DJ
    J Psychosom Res; 2006 Oct; 61(4):479-84. PubMed ID: 17011355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality and morbidity among HIV type-1-infected patients during the first 5 years of a multicountry HIV workplace programme in Africa.
    Van der Borght SF; Clevenbergh P; Rijckborst H; Nsalou P; Onyia N; Lange JM; de Wit TF; Van der Loeff MF
    Antivir Ther; 2009; 14(1):63-74. PubMed ID: 19320238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4 surveillance in Scotland: perspectives on severe HIV-related immunodeficiency. CD4 Collaborative Group.
    AIDS; 1997 Oct; 11(12):1509-17. PubMed ID: 9342074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro cytopathogenicity of the human immunodeficiency virus (HIV)-1 predicts survival in HIV-infected hemophiliacs independent from CD4 cell count.
    Rockstroh JK; Woitas RP; Brackmann HH; Kupfer B; Kaiser R; Schneweis KE; Sudhop T; Spengler U
    Eur J Med Res; 1998 May; 3(5):223-30. PubMed ID: 9580568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.
    Williams BG; Dye C
    Science; 2003 Sep; 301(5639):1535-7. PubMed ID: 12920302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Durban Declaration. More than 5,000 scientists worldwide affirm that HIV is the cause of AIDS.
    Wise K
    Posit Living; 2000 Aug; 9(7):8-9. PubMed ID: 12492023
    [No Abstract]   [Full Text] [Related]  

  • 11. False-negative HIV viral load in AIDS patients.
    Simons P; Muyldermans G; Lacor P; Zissis G; Lauwers S
    AIDS; 1997 Nov; 11(14):1783-4. PubMed ID: 9386817
    [No Abstract]   [Full Text] [Related]  

  • 12. Maintaining antiretroviral therapy reduces the risk of AIDS-defining events in patients with uncontrolled viral replication and profound immunodeficiency.
    Kousignian I; Abgrall S; Grabar S; Mahamat A; Teicher E; Rouveix E; Costagliola D;
    Clin Infect Dis; 2008 Jan; 46(2):296-304. PubMed ID: 18171266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
    Gandhi T; Wei W; Amin K; Kazanjian P
    Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
    Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
    HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS-associated Kaposi's sarcoma in Northeastern Nigeria.
    Kagu MB; Nggada HA; Garandawa HI; Askira BH; Durosinmi MA
    Singapore Med J; 2006 Dec; 47(12):1069-74. PubMed ID: 17139404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of plasma HIV RNA among highly active antiretroviral therapy users.
    Tarwater PM; Gallant JE; Mellors JW; Gore ME; Phair JP; Detels R; Margolick JB; Muñoz A
    AIDS; 2004 Dec; 18(18):2419-23. PubMed ID: 15622318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS.
    Blattner WA; Oursler KA; Cleghorn F; Charurat M; Sill A; Bartholomew C; Jack N; O'Brien T; Edwards J; Tomaras G; Weinhold K; Greenberg M
    J Infect Dis; 2004 May; 189(10):1793-801. PubMed ID: 15122515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study.
    Lyles RH; Muñoz A; Yamashita TE; Bazmi H; Detels R; Rinaldo CR; Margolick JB; Phair JP; Mellors JW
    J Infect Dis; 2000 Mar; 181(3):872-80. PubMed ID: 10720507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No observed effect of GB virus C coinfection on disease progression in a cohort of African woman infected with HIV-1 or HIV-2.
    Kaye S; Howard M; Alabi A; Hansmann A; Whittle H; Schim van der Loeff M
    Clin Infect Dis; 2005 Mar; 40(6):876-8. PubMed ID: 15736023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of HIV-1 viral load and CD4 lymphocyte count as determinants of progression to AIDS and survival].
    Romeu J; Balagué M; Ruiz L; Marfil S; Puig T; Arnó A; Veny A; Tural C; Sirera G; Clotet B
    Med Clin (Barc); 1998 Jun; 110(20):761-7. PubMed ID: 9666416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.